Activated microglia are a feature of many neurodegenerative disorders, including amyotrophic lateral sclerosis and Alzheimer disease. Conflicting results exist, however, for the effectiveness of anti-inflammatory drugs in such conditions. In this article, Schwartz and Shechter propose a model that describes the complexities of the immune response in neurodegenerative diseases and offer an explanation for why such drugs have so far yielded inconsistent data in this setting.
- Michal Schwartz
- Ravid Shechter
